8-K2026-05-29· deepseek-v4-flash

ACMR · ACM Research, Inc.

0001140361-26-023310

Summary

ACM Research's subsidiary, ACM Shanghai, approved a plan to issue H shares and list on the Hong Kong Stock Exchange, subject to shareholder and regulatory approvals.

Key takeaways

ACM Shanghai board approved H share offering up to 7% of total share capital with 15% over-allotment option.
Proceeds intended for product development, global expansion, working capital, and debt repayment.
The listing remains subject to shareholder approval and multiple regulatory clearances.

Full analysis

The subsidiary's board approval marks a strategic step to access international capital markets, but the transaction is contingent on shareholder vote and approvals from Chinese and Hong Kong regulators, introducing execution risk.